Key genes in lung cancer translational research: A meta-analysis

Pathobiology

Volumn 77, Issue 2, 2010, Pages 53-63

  Amelung, J T ^a   Buhrens R ^a   Beshay, M ^b,c   Reymond, M A ^b,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

CDNA array; Lung cancer; Meta analysis; Non small cell lung cancer; Small cell lung cancer; Translational research

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 5; CYTOKERATIN 6; DUAL SPECIFICITY PHOSPHATASE 6; MUCIN 1; PROTEIN P63; PROTEIN S 100; TRANSCRIPTION FACTOR MASH1;

AMINO ACID SEQUENCE; ARTICLE; BPA1 GENE; CANCER RESEARCH; DNA MICROARRAY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; H2AFZ GENE; HUMAN; INSM1 GENE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNAS1 GENE; SGNE1 GENE; SQUAMOUS CELL CARCINOMA; TFF 3 GENE; UNINDEXED SEQUENCE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSLATIONAL RESEARCH;

EID: 77950121330     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000278292     Document Type: Article

References (48)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
2. Travis WD, Brambilla E, Müller-Hermelink KK, Harris CC (eds): Pathology and Genetics of Tumours of the Lung, Thymus And Heart (World Health Organization Classification of Tumours). Lyon, IARC Press, 2004.
3. Rosai J: Surgical Pathology, ed 9. Edinburgh, Mosby, 2004.
4. Yang X, Sun X: Meta-analysis of several gene lists for distinct types of cancer: a simple way to reveal common prognostic markers. BMC Bioinformatics 20076; 8: 118.
5. Srour N, Reymond MA, Steinert R: Lost in translation? A systematic database of gene expression in breast cancer. Pathobiology 2008; 75: 112-118.
6. Chen JJ, Hsueh HM, Delongchamp RR, Lin CJ, Tsai CA: Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data. BMC Bioinformatics 2007; 8: 412.
7. http://www.ornl.gov/sci/techresources/Human- Genome/project/info. shtml(accessed September 15, 2008).
8. Bernier G, Mathieu M, De Repentigny Y, Vidal SM, Kothary R: Cloning and characterization of mouse ACF7, a novel member of the dystonin subfamily of actin binding proteins. Genomics 1996; 38: 19-29.
9. Taintor AR, Leiferman KM, Hashimoto T, Ishii N, Zone JJ, Hull CM: A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia. J Am Acad Dermatol 2007; 56(5 suppl):S73-S76.
10. Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A: Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 2003; 162: 1807-1815.
11. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, Minna JD: Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66: 2116-2128.
12. Osada H, Tatematsu Y, Yatabe Y, Horio Y, Takahashi T: ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res 2005; 65: 10680-10685.
13. Lee JE, Raines RT: Ribonucleases as novel chemotherapeutics: the ranpirnase example. BioDrugs 2008; 22: 53-58.
14. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T: The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007; 67: 8633-8642.
15. Kargi A, Gurel D, Tuna B: The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007; 15: 415-420.
16. Paschoud S, Bongiovanni M, Pache JC, Citi S: Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol 2007; 20: 947-954.
17. Tobioka H, Tokunaga Y, Isomura H, Kokai Y, Yamaguchi J, Sawada N: Expression of occludin, a tight-junction-associated protein, in human lung carcinomas. Virchows Arch 2004; 445: 472-476.
18. Katoh M: Trefoil factors and human gastric cancer. Int J Mol Med 2003; 12: 3-9. (Review.)
19. Mathelin C, Tomasetto C, Rio MC: Trefoil factor 1 (pS2/TFF1), a peptide with numerous functions.Bull Cancer 2005; 92: 773-781. (Article in French.)
20. Mossman BT, Lounsbury KM, Reddy SP: Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 2006; 34: 666-699.
21. Romero P: Current state of vaccine therapies in non-small-cell lung cancer. Clin Lung Cancer 2008; 9(suppl 1):S28-S36. (Review.)
22. Ojika T, Imaizumi M, Abe T, Kato K: Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer. Cancer 1991; 67: 2153-2158.
23. Dallüge KH, Eule H, Schulze G: Increase in serum aldolase caused by bronchial carcinoma. Arch Geschwulstforsch 1984; 54: 387-390. (Article in German.)
24. Stoffers M, Goldmann T, Branscheid D, Galle J, Vollmer E: Transcriptional activity of surfactant-apoproteins A1 and A2 in non small cell lung carcinomas and tumor-free lung tissues. Pneumologie 2004; 58: 395-399. (Article in German.)
25. Ota T, Maeda M, Suto S, Tatsuka M: LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane. Mol Carcinog 2004; 39: 206-220.
26. Pedersen N, Pedersen MW, Lan MS, Breslin MB, Poulsen HS: The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer. Cancer Gene Ther 2006; 13: 375-384.
27. Vieau D, Rojas-Miranda A, Verley JM, Lenne F, Bertagna X: The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumours in man. Clin Endocrinol (Oxf) 1991; 35: 319-325.
28. Ceppi P, Volante M, Ferrero A, Righi L, Rapa I, Rosas R, Berruti A, Dogliotti L, Scagliotti GV, Papotti M: Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors. Clin Cancer Res 2008; 14: 1059-1064.
29. Zheng Z, Li X, Schell MJ, Chen T, Boulware D, Robinson L, Sommers E, Bepler G: Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer 2008; 112: 2765-2773.
30. Rosti G, Carminati O, Monti M, Tamberi S, Marangolo M: Chemotherapy advances in small cell lung cancer. Ann Oncol 2006; 17(suppl 5):v99-v102. (Review.)
31. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S: Cyclooxygenase- 2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 2005; 11: 7674-7682.
32. Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, Burstein DE: p63 and TTF-1 immunostaining: a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003; 119: 696-702.
33. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F: Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int J Cancer 2004; 108: 797-804.
34. Charalabopoulos K, Gogali A, Kostoula OK, Constantopoulos SH: Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol 2004; 26: 256-260. (Review.)
35. Fishel I, Kaufman A, Ruppin E: Meta-analysis of gene expression data: a predictor-based approach. Bioinformatics 2007; 23: 1599-1606
36. Reymond MA, Schlegel W: Proteomics in cancer. Adv Clin Chem 2007; 44: 103-142. (Review.)
37. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner P, Sebastiani P, et al.: Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-366.
38. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC: A five-gene signature and clinical outcome in non-smallcell lung cancer. N Engl J Med 2007;356(1): 11-20.
39. Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, et al.: Smoking and cancer- related gene expression in bronchial epithelium and non-small-cell lung cancers. J Pathol 2006;210:192-204.
40. Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, Yasui W, Inai K, Kohno N, Nakamura Y: Gene expression profiles of smallcell lung cancers: molecular signatures of lung cancer. Int J Oncol 2006;29:567-575
41. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al.: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-13795.
42. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D, Petersen I: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001;98:13784-13789.
43. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002;8:1127-1138.
44. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-824.
45. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, et al.: Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 2004;64:844-856.
46. Wikman H, Seppanen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio- Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmen J, Knuutila S, Anttila S: Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 2004;203:584-593.
47. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P: Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 2002;21:7749-7763.
48. Nakamura H, Saji H, Ogata A, et al.: cDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomas. Cancer 2003;97:2798-2805.